NP / PA
Grisham, Jessica
Grisham, Jessica was paid $186K by Medicaid between Jun 2023 and Dec 2024, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoGRISHAM, JESSICA
CARBONDALE, IL 62901
CARBONDALE, IL 62901
33aNPI1134841125assigned 09/15/2022
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$186K
24GClaims4,127
24DCodes billed23
24AFirst – last monthJun 2023 – Dec 2024
Compared with peers
Next to other Women's Health Nurse Practitioner providers in Illinois
Rank by total paid#18 of 82
Median peer was paid$50K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 770 | $49K | |
| 2024incomplete | 3,357 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 664 | 510 | $69K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 10.0% | 207 | 135 | $19K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 9.0% | 387 | 346 | $17K |
| 0502F | 8.4% | 151 | 121 | $16K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.4% | 187 | 168 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.6% | 329 | 247 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.6% | 329 | 247 | $12K |
| 86780 | 3.0% | 390 | 347 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 87 | 70 | $4K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.1% | 138 | 87 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 439 | 386 | $2K |
| 86803 | 1.2% | 151 | 126 | $2K |
11 more codes
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 51 | $1K |
| 87340 | <1% | 126 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 32 | $1K |
| 86762 | <1% | 86 | $857.38 | |
| 81025 | <1% | 102 | $567.72 | |
| 96127 | <1% | 33 | $481.80 | |
| 82950 | <1% | 106 | $480.60 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 68 | $461.90 |
| 96160 | <1% | 32 | $451.73 | |
| 84702 | <1% | 16 | $167.13 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $166.77 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.